Global Financial Private Client’s West Pharmaceutical WST Stock Holding History

Global Financial Private Client’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-80	Closed	-$17.9K	–	1614
2025 Q1	$17.9K	Buy	80 +42	+111%	+$11.6K	0.01%	472
2024 Q4	$12.4K	Sell	38 -9	-19%	-$2.83K	﹤0.01%	511
2024 Q3	$14.1K	Buy	47 +25	+114%	+$7.66K	0.01%	487
2024 Q2	$7.25K	Hold	22	–	–	﹤0.01%	476
2024 Q1	$8.71K	Hold	22	–	–	﹤0.01%	474
2023 Q4	$7.75K	Hold	22	–	–	﹤0.01%	483
2023 Q3	$8.15K	Hold	22	–	–	﹤0.01%	462
2023 Q2	$8.32K	Hold	22	–	–	﹤0.01%	460
2023 Q1	$7.63K	Hold	22	–	–	﹤0.01%	472
2022 Q4	$5.18K	Hold	22	–	–	﹤0.01%	484
2022 Q3	$5.63K	Hold	22	–	–	﹤0.01%	460
2022 Q2	$6.77K	Hold	22	–	–	﹤0.01%	434
2022 Q1	$9.18K	Hold	22	–	–	﹤0.01%	416
2021 Q4	$10.3K	Hold	22	–	–	0.01%	392
2021 Q3	$9.23K	Hold	22	–	–	﹤0.01%	358
2021 Q2	$7.99K	Hold	22	–	–	﹤0.01%	376
2021 Q1	$6.26K	Hold	22	–	–	﹤0.01%	343
2020 Q4	$6.23K	Hold	22	–	–	﹤0.01%	338
2020 Q3	$6.07K	Hold	22	–	–	0.01%	330
2020 Q2	$4.95K	Hold	22	–	–	﹤0.01%	391
2020 Q1	$3.3K	Hold	22	–	–	﹤0.01%	416
2019 Q4	$3.31K	Buy	+22	New	+$3.2K	﹤0.01%	437

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Global Financial Private Client's WST Position: Q2 2025 in Review

Global Financial Private Client sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 80 shares — an estimated $17.9K sold.

Global Financial Private Client first reported a position in WST in Q4 2019 and held it in 22 quarters. The position peaked at $17.9K in Q1 2025. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

Global Financial Private Client reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
Global Financial Private Client sold 80 West Pharmaceutical shares in Q2 2025, an estimated $17.9K.
Global Financial Private Client first reported a position in West Pharmaceutical in Q4 2019 and held it in 22 quarters.
Global Financial Private Client's West Pharmaceutical position peaked at $17.9K in Q1 2025.
730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.